- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Priority Health’s Joyce Chan Russell Named Emerging Industry Leader
Priority Health's senior vice president of government markets, Joyce Chan Russell, MBA, has been recognized for her innovative work at improving equitable access to health care with an Emerging Industry Leader award.
Grand Rapids, Michigan — Priority Health has announced that its senior vice president of government markets, Joyce Chan Russell, MBA, has been named a 2022 Emerging Industry Leader. She joined Priority Health in August 2021.
Russell is in charge of the health plan’s individual, Medicare Advantage, and Medicaid markets, with her current work aiming to support the annual enrollment and open enrollment periods in Michigan. Recognized for her innovative work at improving equity in access to health care, she is responsible driving growth, fostering partnerships with industry and government stakeholders, and ensuring quality and operational goals are met.
“I am truly honored to receive this award and am proud to lead such a dedicated and talented team of professionals,” Russell said. “Supporting health care for vulnerable populations is one of my great passions, and I’m thankful to be part of an organization that values creative thinking, is committed to achieving health equity, and is focused on making care and coverage better for everyone.”
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
What We’re Reading: New HPV Screenings; Lung Cancer Pills; Migraine Relief Device
November 9th 2023A study suggests that human papillomavirus (HPV) screenings should be updated due to effective HPV vaccines; a new study shows that osimertinib (Tagrisso, AstraZeneca) reduced both the 5-year risk of recurrent cancer and the risk of death in patients with stage 1B to 3A lung cancer; a new smartphone-controlled technology could help those who suffer from migraines.
Read More
